welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!

CureDuchenne Ventures Announces The “CureDuchenne Ventures 2020 Pitch Contest,” To Award Two $25,000 Prizes For Novel Ideas In Duchenne Muscular Dystrophy Therapy Development


NEWPORT BEACH, Calif., June 9, 2020 /PRNewswire/ –­­­ CureDuchenne Ventures, the venture funding arm of CureDuchenne, a leading global nonprofit dedicated to funding and finding a cure for Duchenne muscular dystrophy, today announced the first ever CureDuchenne Ventures 2020 Pitch Contest. The goal of this effort is to continue to find and support innovations in Duchenne therapy development, despite COVID-19 restricting the research community’s ability to meet in person at conferences and workshops. 

“While we have a long history of investments in early-stage Duchenne companies, we are expanding our model to create no-strings attached awards,” said CEO and Founder of CureDuchenne, Debra Miller. “We are most interested in new therapeutic targets, as well as novel solutions for overcoming limitations of therapies currently in development, such as immune-targeting approaches to make gene therapy more widely accessible. Our recent $1M seed investment into Myosana Therapeutics, exemplifies our commitment to funding and supporting next generation gene therapy research.”

CureDuchenne Ventures Announces The “CureDuchenne Ventures 2020 Pitch Contest,” To Award Two $25,000 Prizes For Novel Ideas In Duchenne Muscular Dystrophy Therapy Development